2724. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Healthy Meningococcal Vaccine-Naïve Children (2–9 Years)

BACKGROUND: MenACYW-TT is an investigational quadrivalent meningococcal conjugate vaccine that contains tetanus toxoid as carrier protein. The vaccine is intended for global use in individuals 6 weeks of age and older. We evaluated the safety and immunogenicity of MenACYW-TT compared with a licensed...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Michael W, Brandon, Donald, Christensen, Shane, Baccarini, Carmen, Jordanov, Emilia, Dhingra, Mandeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809978/
http://dx.doi.org/10.1093/ofid/ofz360.2401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809978/
http://dx.doi.org/10.1093/ofid/ofz360.2401

Ejemplares similares